Download:
pdf |
pdfTVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
A. DEMOGRAPHICS
Last Name2000:
SSN2030:
First Name2010:
-
□ SSN N/A2031 Patient ID2040:
-
Birth Date2050:
Sex2060:
mm / dd / yyyy
Other ID2045:
(auto)
Hispanic or Latino Ethnicity2076:
O Male O Female
□ White2070
□ American Indian/Alaskan Native2073
Race:
(check all that apply)
Middle Name2020:
□ Black/African American2071
□ Native Hawaiian/Pacific Islander2074
O No
O Yes
□ Asian2072
B. EPISODE OF CARE
Arrival Date/Time3000,3001:
Residence3003:
mm / dd / yyyy HH:MM
O Home w/no health-aid
O Home w/health-aid
3005
Insurance Payors: □ Private Health Insurance
(check all that apply) □ State-Specific Plan (non-Medicaid)3009
HIC3015:
Research Study3030:
O Long-term care
O Other
3006
O Not Documented
3007
□ Military Health Care3008
□ Non-US Insurance3011 □ None3012
□ Medicare
□ Medicaid
□ Indian Health Service3010
O No
àIf Yes, Study Patient ID3032:
O Yes
C. HISTORY AND RISK FACTORS (PATIENT HISTORY AND RISK FACTORS UP TO THE PROCEDURE)
CARDIAC HISTORY
Infective Endocarditis4000:
O No
àIf Yes, Infective Endocarditis Type4005:
O Treated
O Yes
O Active
Heart Failure Hospitalization w/in Past Year4006:
O No
O Yes
O Not Documented
àIf Yes, CRT4013:
Previous ICD4015:
àIf Yes, CRT–D4016:
Prior PCI4020:
Prior CABG4030:
# Previous Cardiac Surgeries
:
Prior Aortic Valve Procedure4060:
àIf Yes, AV Replacement – Surgical
àIf Yes, AV Repair – Surgical
4080
:
:
àIf Yes, AV Transcatheter Valve
Replacement4090:
O No
O Yes – partial
O Yes – circumferential
O No
O No
O Yes
O No
O Yes
àIf Yes, MV Transcatheter Intervention4112:
O No
O Yes
àIf Yes, Mitral Transcather Type4113 :
O No
O Yes
O No
O Yes
O Yes
O No
O Yes
O No
O Yes
O No
O Yes
O No
O Yes
O Yes
àIf Yes, Mitral Annuloplasty Ring–Surgical4111:
O Yes
O No
O Yes
àIf Yes, Most Recent MV Procedure Date4097: mm / dd / yyyy
O No
O 0 O 1 O 2 O 3 O >=4
4070
O No
àIf Yes, MV Repair – Surgical4110:
Permanent Pacemaker4010:
4055
Prior Non Aortic Valve Procedure4095:
O Leaflet clip
O Coronary sinus based intervention
O Valve-in-Valve
O Not Documented
O No
O Yes
O Direct annuloplasty intervention
O Valve-in-native Valve
O Other
àIf Yes, Prior Tricuspid Valve
Repair/Replacement4118:
O No
O Yes
àIf Yes, Prior Pulmonic Valve
Repair/Replacement4119:
O No
O Yes
O No
O Yes
OTHER HISTORY AND RISK FACTORS
Prior Stroke4120:
4125
àIf Yes, Most Recent Stroke Date
4130
Transient Ischemic Attack
4135
Carotid Stenosis
:
mm / dd / yyyy
O No
:
: O None
O Right
O Left
O Yes
Diabetes Mellitus4165:
4170
àIf Yes, Diabetes Therapy
O None
O Diet
4175
O Both O NA Currently on Dialysis
:
O Oral
O Insulin
O Other
O No
:
O Yes
àIf Yes, Prior CEA/CAS 4140:
O No
O Yes
Chronic Lung Disease4180: O None O Mild O Moderate O Severe
Peripheral Arterial Disease4145:
O No
O Yes
Home Oxygen4181:
Current Smoker
Hypertension
4150
4155
(w/in 1 year):
:
© 2011 STS and ACCF
O No
O No
O Yes
O Yes
Hostile Chest
4182
:
Immunocompromise Present
6/9/2014 11:59 AM
4185
:
O No
O Yes
O No
O Yes
O No
O Yes
Page 1 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
HOME MEDICATIONS
ACE or ARB (any)4200,4205 :
O No
O Yes
Diuretics – Aldosterone Antagonists4200,4205 :
O No
O Yes
Anticoagulants (any)4200,4205:
O No
O Yes
Diuretics – Loop diuretic4200,4205 :
O No
O Yes
O No
O Yes
O No
O Yes
4200,4205
Aspirin (alone)
:
O No
4200,4205
Aspirin (dual antiplatelet therapy)
4200,4205
Beta Blockers (any)
:
O No
:
àIf Loop Diuretic, Dose
O Yes
O Yes
O No
O Yes
4210
:_____mg
4200,4205
Diuretics – Thiazides
:
4200,4205
Diuretics (not otherwise specified)
:
D. PRE-PROCEDURE STATUS (COMPLETE FOR THE PROCEDURE)
CAD Presentation5000: O No Sxs, no angina (14 days)
O Unstable angina (60 days)
Prior MI5005:
O No
5012
Cardiomyopathy
:
O Sx unlikely to be ischemic (14 days)
O Stable angina (42 days)
O Non-STEMI (7 days)
O STEMI (7 days)
àIf Yes, Prior MI Timeframe5010:
O Yes
O < 30 Days
O >= 30 days
O Yes – Ischemic O Yes – Non-ischemic
O No
Heart Failure w/in 2 Weeks5020:
O No
O Yes
STS Risk Score (MV replace)5106: _______ %
O III
O IV
STS Risk Score (MV repair)5107:
Cardiogenic Shock w/in 24 Hours5030:
O No
O Yes
Six Minute Walk Test5115:
Cardiac Arrest w/in 24 Hours5035:
O No
O Yes
Porcelain Aorta5045:
O No
O Yes
O No
O Yes
NYHA Class w/in 2 Weeks5025:
Atrial Fibrillation/Flutter
5050
OI
O II
:
àIf Yes, AF Class w/in past 30 days5052:
O None O Persistent O Paroxysmal
O Performed
O Not performed – non-cardiac reason
O Not performed – cardiac reason
O Not performed – patient not willing to walk
O Not performed by site
Test Date5116:
mm / dd / yyyy
5117
KCCQ-12 Performed5169: O No
àIf Yes, KCCQ-12
5170-5181
:
_______ %
Total Distance
: ___________ ft
Q3:
O Yes
Q1a: _______
Q1b: _______
Q1c: _______
Q2:
Q5:
Q6:
Q7:
Q8a: _______
_______
_______
Q4:
_______
(See separate questionnaire)
_______
_______
_______
Q8b: _______
Q8c: _______
CLINICAL DATA (CLOSEST TO THE PROCEDURE)
Height5200: ___________ cm
Weight5205: ___________ kg
Hemoglobin5250: _______ g/dL
□ Not Drawn5251
Creatinine5255: _______ mg/dL
□ Not Drawn5256
BNP5277: ______pg/mL
NT proBNP5278: _____pg/mL
FEV1 Predicted5280: _______ %
□ Not Performed5281
DLCO (Adjusted)5285: _______ %
□ Not Performed5286
(OR)
□ Not Drawn5279
QRS Duration5290: ________ msec
□ Ventricular Paced5291
MEDICATIONS (ADMINISTERED WITHIN 24 HOURS PRIOR TO THE PROCEDURE)
Inotropes5400,5405(positive):
© 2011 STS and ACCF
O No O Yes O Contraindicated O Blinded
6/9/2014 11:59 AM
Page 2 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
DIAGNOSTIC CATH FINDINGS
Number of Diseased Vessels5506:
5507
Left Main Stenosis >=50%
5565
LVEF
:
:
O None
O No
O1
O2
O3
O Yes
□ LVEF Not Assessed5566
________ %
□ Not Performed5569
Cardiac Output5567: _________ mL/min
Pulmonary Capillary Wedge Pressure5590:
_________ mmHg
□ Not Measured5591
Pulmonary Artery Pressure (mean)5593:
_________ mmHg
□ Not Measured5594
Pulmonary Artery Pressure (systolic)5596:
_________ mmHg
□ Not Measured5597
Right Atrial Pressure/CVP (mean)5598:
_________ mmHg
□ Not Measured5599
ECHOCARDIOGRAM FINDINGS
Left Ventricular Internal Systolic Dimension5595:
______ cm
□ Not Measured5608
Left Ventricular Internal Diastolic Dimension5600:
______ cm
□ Not Measured5609
Left Ventricular End Systolic Volume5601:
______ ml
□ Not Measured5602
Left Ventricular End Diastolic Volume5603:
______ ml
□ Not Measured5604
Left Atrial Volume5606: ____ mL (OR) LA Volume Index5607:
Aortic Regurgitation5630 (highest): O None
Aortic Stenosis5665:
5685
Mitral Valve Disease
:
O No
O Yes
O No
O Yes
_____ mL/m2
O Trace/Trivial
O 1+ (mild)
O 2+ (moderate)
O 3-4+ (severe)
àIf Yes, complete the following:
Mitral Regurgitation5695 (highest): O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe)
O 4+ (severe)
Note: According to American Society of Echocardiography Guidelines
Effective Orifice Area (EOA) or EROA 5698:
5705
Mitral Valve Stenosis
MV Area5710:
:
O No
________ cm2
O Yes
O PISA
O Other
MV Mean Gradient5715 (highest): ________ mmHg
________ cm2
Tricuspid Regurgitation5735:
Method of Assessment5699: O 3D Planimetry
O Quantitative Doppler
O None
O Trace/Trivial
O Mild
O Moderate
O Severe
Mitral Valve Disease Etiology (check all that apply):
□ Functional Mitral Regurgitation (FMR)5745
□ Degenerative Mitral Regurgitation (DMR)5746
□ Endocarditis5748
□ Other/Indeterminate5749
àIf FMR is Yes, Functional
Type5755:
àIf DMR is Yes, Leaflet
Prolapse5760:
àIf DMR is Yes, Leaflet
Flail5765:
àIf Inflammatory is Yes,
Type5770:
© 2011 STS and ACCF
□ Post – Inflammatory5747
O Ischemic-acute, post infarction O Ischemic-chronic
O Non-ischemic dilated cardiomyopathy
O Restrictive cardiomyopathy
O Hypertrophic cardiomyopathy
O Pure annular dilation (w/normal LV systolic fx)
O Not Documented
O None O Anterior
O Not Documented
O Posterior
O Bi-leaflet
O None O Anterior
O Not Documented
O Posterior
O Bi-leaflet
O Idiopathic
O Prior radiation Rx
O Collagen vascular disease
O Drug induced O Rheumatic fever history O Not Documented
6/9/2014 11:59 AM
Page 3 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
ECHOCARDIOGRAM FINDINGS
Mitral Leaflet Calcification5810:
O Yes O No
O Not Documented
Leaflet Tethering5775: O None
O Anterior
O Posterior
O Yes O No
O Not Documented
5800
Mitral Annular Calcification
:
O Bi-leaflet
Carpentier’s Functional Class of Mitral Regurgitation5820: O Type I
O Type II
O Not Documented
O Type IIIa
O Type IIIb
O Not Documented
LEAFLET CLIP PROCEDURE REASONS/INDICATIONS (CHECK ALL THAT APPLY)
□ Frailty5900 (assessed by in-person cardiac surgeon consultation)
□ Hostile Chest5901
□ Severe Liver Disease (Cirrhosis or MELD score >12)5902
□ Porcelain Aorta5903 (or extensively calcified ascending aorta)
□ Predicted STS MV Repair Operative Mortality Risk of >=6% (for patients deemed likely to undergo MV repair)5905
□ Predicted STS MV Replacement Operative Mort Risk >=8% (for patients deemed likely to undergo MV replacement)5904
□ Unusual Extenuating Circumstance5906
àIf Unusual Extenuating Circumstance, check all that apply:
□ Right Ventricular Dysfunction w/Severe Tricuspid Regurg5907 □ Chemotherapy for Malignancy5908 □ Major Bleeding Diathesis5909
□ Immobility5910
□ Other5915
□ Severe Dementia5912
□ AIDS5911
□ High Risk of Aspiration5913
□ IMA at High Risk of Injury5914
àIf Other , Specify 5916 (provide reason why patient is prohibitive risk): _________________________
E. PROCEDURE INFORMATION (COMPLETE FOR EACH LEAFLET CLIP PROCEDURE)
Procedures
□ Transcatheter Aortic Valve Replacement6600 □ Transcatheter Mitral Valve Replacement6601 □ Mitral Leaflet Clip Procedure6602
Other Procedure Performed Concurrently6620:
O No
O Yes – PCI O Yes – Other
Operator A Name6000,6005,6010:
Operator A NPI6015:
Operator B Name6020,6025,6030:
Operator B NPI6035:
Procedure Start Date6040,6041: mm / dd / yyyy HH:MM
6055
Procedure Status
:
O Elective
O Urgent
Type of Anesthesia6110: O General anesthesia
6212
Guiding Cath Access Site
:
O Right femoral vein
Leaflet Clip Model ID 26245:
26250
Leaflet Clip Serial #
UDI
26255, 26260, 26265
Location
26270
:
Clip Deployed26275:
àIf No, Reason26280:
© 2011 STS and ACCF
mm / dd / yyyy HH:MM
O Emergency
O Moderate sedation
Steerable Guide Model ID26180: ____________
Leaflet Clip Counter26240:
Procedure Stop Date6045,6046:
O Salvage
O Epidural
O Combination
O Left femoral vein O Jugular vein
O Other vein
Steerable Guide Cath Serial Number26182: ____________
Leaflet Clip #1
Leaflet Clip #2
Leaflet Clip #3
Refer to Device List
Refer to Device List
Refer to Device List
(future)
(future)
(future)
O A1P1
O A2P2
O A3P3
O A1P1
O A2P2
O A3P3
O A1P1
O A2P2
O A3P3
:
O No
O Yes
O Inability to grasp leaflets
O Inability to reduce MR
O Mitral stenosis
O MV injury
O Device malfunction
O Adverse event
O Other
O No
O Yes
O Inability to grasp leaflets
O Inability to reduce MR
O Mitral stenosis
O MV injury
O Device malfunction
O Adverse event
O Other
6/9/2014 11:59 AM
O No
O Yes
O Inability to grasp leaflets
O Inability to reduce MR
O Mitral stenosis
O MV injury
O Device malfunction
O Adverse event
O Other
Page 4 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
POST IMPLANT
Mitral Regurgitation26285: O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe)
O 4+ (severe)
Note: According to American Society of Echocardiography Guidelines
MV Mean Gradient26290: ________ mmHg
Conversion to Open Heart Surgery26105:
Mechanical Assist Device
àIf Yes, Timing26141:
àIf Yes, Type
26142
26140
:
O IABP
O No
O Yes
O Catheter-based assist device
Cardiopulmonary Bypass Used6100:
àIf Yes, Status
O Yes
O Pre-procedure O Intra-procedure O Post-procedure
:
6101
O No
O Elective
:
O No
O Yes
àIf Yes, CPB Time 6105: ______mins
O Emergent
Radiation Dose Measurement Method6455: O Single Plane
Fluoroscopy Time
6460
Cumulative Air Kerma6465: _____ mGy
: _______ mins
Dose Area Product6470: _______
Procedure Room
Anesthesia
Procedure Access
Transseptal Access
O Gy-cm2 O cGy-cm2
àDAP Units6475:
Procedure Duration
O Biplane
O mGy-cm2 O µGy-M2
Start Time
Arrival Date/Time26060,26061
Stop Time
mm / dd / yyyy HH:MM
26070
26071
HH:MM Discontinuation
Induction
Vascular or TEE Access
Transseptal Access
26075
HH:MM
HH:MM Last Cath/TEE Removed
26080
26076
HH:MM
26081
HH:MM Septum Crossed
SCG in Intra-atrial Septum
26086
HH:MM
HH:MM Delivery System Retracted
Device
26091
SCG Device Removal (from fem vein)
HH:MM
26096
HH:MM
F. ADVERSE EVENTS, INTERVENTIONS AND SURGERIES (COMPLETE FOR EACH PROCEDURE. SPECIFY EVENT DATE FOR EACH EVENT OCCURRENCE.)
àIf Yes, specify the Event7301 and Event Date(s)7302:
mm / dd / yyyy
Cardiac ArrestE005:
mm / dd / yyyy
EndocarditisE003:
mm / dd / yyyy
E001
Myocardial Infarction
:
mm / dd / yyyy
Transient Ischemic AttackE010
(complete Adjudication):
mm / dd / yyyy
E011
Neuro
O Yes
Atrial Fibrillation (new onset)E006:
Ischemic Stroke
(complete Adjudication):
mm / dd / yyyy
E012
Hemorrhagic Stroke
(complete Adjudication):
mm / dd / yyyy
Perforation
(w/ or w/o Tamponade)E009:
mm / dd / yyyy
Mitral Leaflet Injury
(detected during surgery)E045:
mm / dd / yyyy
Single Leaflet Device Attachment E049:
mm / dd / yyyy
Mitral Leaflet Injury
(ascertained by echo)E046:
mm / dd / yyyy
Complete Detachment of Leaflet Clip
(from valve leaflets)E051:
mm / dd / yyyy
mm / dd / yyyy
Mitral Subvalvular Injury
(ascertained by echo)E048:
mm / dd / yyyy
New Requirement for DialysisE029:
mm / dd / yyyy
© 2011 STS and ACCF
Stroke (Undetermined Type)
(complete Adjudication):
Device/Delivery System
Mitral Subvalvular Injury
(detected during surgery)E047:
Renal
Valve
Cardiac
Intra or Post Procedure Events Occurred7300: O No
Device Embolization
E050
E013
:
Delivery system
component embolizationE058:
E027
Device Thrombosis
:
Other Device/Delivery System
Related EventE028:
6/9/2014 11:59 AM
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
mm / dd / yyyy
Page 5 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
F. ADVERSE EVENTS, INTERVENTIONS AND SURGERIES (COMPLETE FOR EACH PROCEDURE. SPECIFY EVENT DATE FOR EACH EVENT OCCURRENCE.)
mm / dd / yyyy
:
mm / dd / yyyy
Retroperitoneal BleedingE019:
mm / dd / yyyy
Hematoma at Access Site
Bleed/Vascular
E018
àIf Yes, specify the Event7301 and Event Date(s)7302:
E020
GI Bleed
:
mm / dd / yyyy
GU BleedE021:
mm / dd / yyyy
Other BleedE022:
mm / dd / yyyy
Transseptal ComplicationE052:
mm / dd / yyyy
Vascular
Bleeding at Access SiteE017:
O Yes
Major Vascular Access
Site ComplicationE041:
mm / dd / yyyy
Minor Vascular Access
Site ComplicationE042:
mm / dd / yyyy
E053
Additional Procedures
Intra or Post Procedure Events Occurred7300: O No
Mitral Valve Re-intervention
(complete Adjudication):
mm / dd / yyyy
Unplanned Other Cardiac Surgery
or InterventionE031(not MVR):
mm / dd / yyyy
Unplanned Vascular Surgery or InterventionE032
mm / dd / yyyy
(for Bleeding or Access Site Complication)
ASD Closure Due To Transseptal
CatheterizationE054:
mm / dd / yyyy
G. POST-PROCEDURE LABS AND TESTS
Lowest Hemoglobin8040: _______ g/dL
Echocardiogram8065:
Date8070:
□ Not Drawn8041
O Not Performed
O Yes - TTE
Highest Creatinine8050: ______ mg/dL
□ Not Drawn8051
àIf Yes, complete the following:
O Yes - TEE
mm / dd / yyyy
Mitral Regurgitation8075: O None O Trace/Trivial O 1+ (mild) O 2+ (moderate) O 3+ (moderate – severe)
O 4+ (severe)
Note: According to American Society of Echocardiography Guidelines
Effective Orifice Area (EOA) or EROA 8122: ________ cm2
Method of Assessment8125: O 3D Planimetry
O PISA
O Quantitative Doppler O Other
Mean Mitral Gradient8130: ________ mmHg
H. DISCHARGE (COMPLETE FOR EACH EPISODE OF CARE)
RBC/Whole Blood Transfusion9011: O No
O Yes
àIf Yes, # Units Transfused9012: ________ Note: Code the total # of units between start
of the procedure and discharge
Number of Hours in ICU9040:
9045
Discharge Date
________
Discharge Status9050:
: mm / dd / yyyy
àIf Alive, Discharge Location9055:
O Home
O Nursing home
àIf Deceased, Death in Lab/OR9060:
O No
àIf Deceased, Primary Cause of Death9065:
O Alive
O Deceased
O Extended care/TCU/rehab
O Hospice
O Other
O Other acute care hospital
O Left against medical advice (AMA)
O Yes
O Cardiac
O Valvular
O Neurologic
O Pulmonary
O Renal
O Unknown
O Vascular
O Other
O Infection
DISCHARGE MEDICATIONS (NOT REQUIRED FOR PTS WHO EXPIRED OR WERE DISCHARGED TO ‘OTHER ACUTE CARE HOSPITAL’, ‘HOSPICE’, OR ‘AMA’)
ACE/ARB9100,9105(any):
O No
O Yes
O Contraindicated
O Blinded
Anticoagulants (any)9100,9105
O No
O Yes
O Contraindicated
O Blinded
O No
O Yes
O Contraindicated
O Blinded
O No
O Yes
O Contraindicated
O Blinded
O No
O Yes
O Contraindicated
O Blinded
O No
O Yes
O Contraindicated
O Blinded
O No
O Yes
O Contraindicated
O Blinded
Diuretics (not otherwise specified)9100,9105:
O No
O Yes
O Contraindicated
O Blinded
Diuretics – Thiazides9100,9105:
O No
O Yes
O Contraindicated
O Blinded
9100,9105
Aspirin (alone)
:
Aspirin (dual antiplatelet therapy) 9100,9105:
9100,9105
Beta Blockers (any)
:
Diuretics – Aldosterone Antagonists9100,9105:
9100,9105
Diuretics – Loop
:
àIf Loop Diuretic, Dose9110: _____mg
© 2011 STS and ACCF
6/9/2014 11:59 AM
Page 6 of 9
STS/ACC TVT Registry·
tit'(§)
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures Leaflet Clip
I. F OLLOW-UP (30 DAYS, 1 YEAR FROM DATE OF PROCEDURE)
Last Name
2000
2010
:
First Name
:
Reference Procedure Start Date 6040 :
Assessment Date
10000
Patient ID
2045
Other ID
:
:
10005
: 0 Clinic
Study Patient ID
0 Medical record
10010
: 0 Alive
Status
0 Home w/health-aid
:
~If Deceased, Date of Death
10020
0 Other
0 Other
0 Not documented
0 Withdrawn
o cardiac
0 Neurologic
0 Rena l
0 Vascular
0 Valvular
0 Pulmonary
0 Unknow n
0 Other
0 Infection
:
o Not Drawn 100~atinine 10090: _ _ _ mg/dL
Hemoglobin10085: - g/dL
NYHA Classification at Follow-up
10100
0 I
:
: 0 Not Performed
Date10207:
0 Social Security death master fi le
0 Long-term care
0 Lost to follow-up
0 Deceased
~If Deceased, Primary Cause of Death10015:
LVEF10210:
3032
0 Letter from medical provider
0 Phone call to patient/family
Residence 10008 : 0 Home w/no health-aid
10206
:
(If the patient has not been discharged at 30 days, capture the 30 day F/U w hile still in the facility.)
Primary Method t o Determine Status
Ec hocardiogram
2040
0 II
0 Ill
0 Yes· TIE
o Not Drawn 10091
0 IV
~If Yes, complete the following
0 Yes- TEE
I
o LVEF Not Assessed10211
--- %
Mitral Regurgitatio n
10300
: 0 None 0 Trace/Trivial 0 1+ (mild) 0 2+ (moderate) 0 3+ (moderate - severe)
0 4+ (severe)
Note: According to American Society of Echocardiography Guidelines
Effective Orifice A rea (EOA) or EROA
10315
:
Method of Assessment
Mean Mitral Gradiene 0030 : ____ mmHg
Left Atrial Volume
10035
10020
: 0 3D Planimetry
0 Quantitative Dopplar
0 PISA
0 Other
: _ _ mL (OR) LA Volume Index 10040 : _ _ mU m2
Left Ventric ular Internal Systo lic Dimensio n 10045:
Left Ventric ular Internal Diasto lic Dimensio n
10055
Left Ventric ular End Systolic Volume
:
Left Ventric ular End Diasto lic Volume
Tric uspid Regurgitatio n
10065
KCCQ-12 Performed10230:
:
:
0 None
:
0 No
~ If Yes, KCCQ-12 10231-10243:
10360
10050
_ _ _ _ em
o Not Measured
_ _ _ _ em
o Not Measured
_ _ _ mL
o Not measured
_ _ _ mL
o Not measured
0 Trace/Trivial
0 Mild
0 Moderate
10346
10351
10356
10361
0 Severe
0 Yes
Q1a: _ __
Q1b:
Q1 c :
Q2:
Q3:
Q4:
Q5:
Q6:
Q7:
QSa: _ __
QSb : _ __
QSc: _ __
(See separate questionnaire)
Six Minute Walk Test Perfo rmed
10380
:
o Performed
0
0
0
0
Total Distance Walked
© 2011 STS and ACCF
10090
:
Not
Not
Not
Not
performed
performed
performed
performed
non-card iac reason
- card iac reason
- patient not w illing to walk
by site
_ _ _ _ ft
6/9/20 14 11 :59 AM
Page 7 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
I. FOLLOW-UP (CONT.) (30 DAYS, 1 YEAR FROM DATE OF PROCEDURE)
ADVERSE EVENTS, READMISSIONS, INTERVENTIONS AND SURGICAL PROCEDURES (SPECIFY THE EVENT DATE FOR EACH EVENT THAT OCCURRED
30-DAY F/U, OR BETWEEN F/U ASSESSMENT DATE #1 AND F/U ASSESSMENT DATE #2.)
BETWEEN DISCHARGE AND
O Yes
Atrial Fibrillation (new onset)E006:
mm / dd / yyyy
EndocarditisE003:
mm / dd / yyyy
Myocardial InfarctionE001:
mm / dd / yyyy
Transient Ischemic Attack
(complete Adjudication):
mm / dd / yyyy
Ischemic StrokeE011(complete Adjudication):
mm / dd / yyyy
Major Vascular Access
Site ComplicationE041:
mm / dd / yyyy
Minor Vascular Access
Site ComplicationE042:
mm / dd / yyyy
E043
Major Bleeding Event
:
mm / dd / yyyy
Life Threatening BleedingE037:
mm / dd / yyyy
E053
Mitral Valve Re-intervention
Hemorrhagic StrokeE012
(complete Adjudication):
mm / dd / yyyy
Stroke (Undetermined Type) E013
(complete Adjudication):
mm / dd / yyyy
Device Embolization E050:
mm / dd / yyyy
Single Leaflet Device Attachment
E049
:
mm / dd / yyyy
Device ThrombosisE027:
Additional Procedures
Device
Neuro
E010
àIf Yes, specify the Event10246 and Event Date(s)10247:
Bleeding/Vascular
O No
mm / dd / yyyy
Other Device Related Event
E028
:
mm / dd / yyyy
New Requirement for DialysisE029:
Renal
mm / dd / yyyy
(complete Adjudication)
mm / dd / yyyy
ASD Closure
Due To Transeptal CatheterizationE054:
mm / dd / yyyy
Unplanned Other Cardiac Surgery
or InterventionE031(not Mitral):
mm / dd / yyyy
Unplanned Vascular Surgery
or InterventionE032
(for Bleeding or Access Site Complication):
mm / dd / yyyy
E055
Readmission
Cardiac
Follow-up Events Occurred10245:
Readmission – Heart Failure
(complete Adjudication):
Readmission – Cardiac (not HF)
Readmission – Non-Cardiac
(Follow Up)E057:
mm / dd / yyyy
E056
:
mm / dd / yyyy
mm / dd / yyyy
FOLLOW-UP MEDICATIONS (MEDICATIONS PRESCRIBED OR TAKEN AT THE TIME OF FOLLOW-UP)
ACE/ARB10250,10255(any):
Beta Blockers
10250,10255
O No O Yes O Contraindicated O Blinded
(any):
O No O Yes O Contraindicated O Blinded
Anticoagulants10250,10255(any):
Aspirin
10250,10255
O No O Yes O Contraindicated O Blinded
(alone):
O No O Yes O Contraindicated O Blinded
Aspirin (dual antiplatelet therapy) 10250,10255:
Diuretics – Aldosterone Antagonists
10250,10255
O No O Yes O Contraindicated O Blinded
:
O No O Yes O Contraindicated O Blinded
Diuretics – Loop10250,10255:
àIf Loop Diuretic, Dose
10257
O No O Yes O Contraindicated O Blinded
: _____ mg
Diuretics (not otherwise specified)10250,10255:
10250,10255
Diuretics – Thiazides
© 2011 STS and ACCF
O No O Yes O Contraindicated O Blinded
:
O No O Yes O Contraindicated O Blinded
6/9/2014 11:59 AM
Page 8 of 9
TVT Registry™ v2.0
Transcatheter Mitral Valve Procedures – Leaflet Clip
J. ADJUDICATION FORM (COMPLETE FOR EACH STROKE, TIA, MITRAL VALVE RE-INTERVENTION, OR HEART FA LURE READMISSION)
Last Name2000:
First Name2010:
Patient ID2040:
Reference Procedure Start Date6040: mm / dd / yyyy
Other ID2045:
Study Patient ID3032: (optional)
Adjudication Event12000: O Ischemic Stroke(In-hospital)
O Hemorrhagic Stroke(In-hospital)
O Mitral Valve Re-intervention(In-hospital)
O Ischemic Stroke(F-U)
O Hemorrhagic Stroke(F-U)
O Mitral Valve Reintervention(F-U)
O Readmission – Heart Failure (F-U)
O Undetermined Stroke(In-hospital)
O TIA(In-hospital)
O Undetermined Stroke(F-U)
O TIA(F-U)
Event Date12005: mm / dd / yyyy
Status12010: O Alive
O Deceased
àIf Deceased, Date of Death12011: mm / dd / yyyy
àIf Event12000 is Stroke or TIA
Date of Symptom Onset12015(approximate):
Neurologic Deficit with Rapid Onset
12025
àIf Yes, Clinical Presentation
:
12020
mm / dd / yyyy
: O No
O Yes
O Stroke/TIA
àIf Stroke/TIA, Symptom Duration > 24 hours
12040
àIf Stroke/TIA, Neuroimaging Performed
àIf Yes, Deficit Type12045:
O No deficit
O Non-Stroke
12030
:
:
O Infarction
O Hemorrhage
àIf Stroke/TIA, Neurologist/Neurosurgeon Confirmation of Diagnosis
12055
O Both (hem/infarc)
:
àIf Stroke/TIA, Social/Recreational Activities Impaired12056:
12057
àIf Stroke/TIA, Neurocognitive Functions Essential to Pt or their Livelihood Impaired:
:
àIf Stroke/TIA, New Aids or Assistance Required:12058:
àIf Stroke/TIA, Death as a Result of Neurologic Deficit
12060
:
O No
O Yes
O No
O Yes
O Subarachnoid Hemorrhage
O No
O Yes
O No
O Yes
O No
O Yes
O No
O Yes
O No
O Yes
Clinical Comments12065(information and details that may assist in assessing the stroke or TIA):
àIf Event12000 is Mitral Valve Re-intervention
Mitral Valve Re-intervention Type12200: O Surgical MV Repair
O Surgical MV Replacement O Transcatheter MV Repair
O Transcatheter MV Replacement O Leaflet Clip Procedure O Other Transcath Intervention
àIf Other Transcatheter Intervention, Other Type12205: ______________________________________________________________
MV Reintervention Indication12210: O Mitral regurgitation
O Device embolization
O Mitral stenosis
O Endocarditis
O Mitral valve injury
O Device thrombosis
O Other
àIf Other, Other Indication12215: __________________________________________________________________________
Clinical Comments12220(information and details that may assist in assessing this re-intervention):
àIf Event12000 is Readmission (Heart Failure)
Hospitalization >=24 hours12225:
12230
Clinical Signs and/or Symptoms of Heart Failure
IV or Invasive Treatment Required12335 :
O No
O Yes
O Information not available
: O No
O Yes
O Information not available
O No
O Yes
O Information not available
Note: IV includes diuretics or vasoactive therapy and Invasive includes ultrafiltration, IABP, or mechanical assistance
© 2011 STS and ACCF
6/9/2014 11:59 AM
Page 9 of 9
File Type | application/pdf |
File Title | TVT Registry v1.1 |
Subject | TVT Registry Data Collection Form |
Author | STS and ACCF |
File Modified | 2014-07-30 |
File Created | 2014-06-09 |